Thermo Fisher Scientific Announces New Chromatography Technologies

News
Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-07-05-2017
Volume 12
Issue 7

The company announced its new ISQ EC Single Quadrupole mass spectrometer and the new range of Thermo Scientific MAbPac RP 1-mm columns.

On June 19, 2017 Thermo Fisher Scientific announced new technologies designed to allow analytical chemists to obtain high-resolution separations. The company is displaying the new technologies at the 46th International Symposium on High Performance Liquid Phase Separations and Related Techniques from June 18–22, 2017, at the Prague Congress Centre.

The new Thermo Scientific ISQ EC Single Quadrupole mass spectrometer (MS) integrates with an existing ion chromatography (IC) or high performance liquid chromatography (HPLC) system and provides small molecule sensitivity and mass confirmation. The Chromeleon Chromatography Data Software platform has embedded ISQ EC MS instrument control, which enables users to minimize time spent on new MS user training. The instrument also enables users to analyze a range of simple and complex sample matrices.

The new range of Thermo Scientific MAbPac RP 1-mm columns are designed for high-performance, reversed-phase chromatography characterization of monoclonal antibodies, fragments, variants, antibody drug conjugates, and proteins. With a 1-mm inner diameter, the new columns provide sensitive analyses of very small sample volumes at low flow rates for direct injection into the LC-MS. The columns include a polymeric resin with an optimized pore size and thermal and pH stability.

Source: Thermo Fisher Scientific 

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content